Protease inhibition in the intestinal lumen: Attenuation of systemic inflammation and early indicators of multiple organ failure in shock

Shock

Volumn 17, Issue 3, 2002, Pages 205-209

  Mitsuoka, Hiroshi ^a   Kistler, Erik B ^a   Schmid Schönbein, Geert W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelium; Free radicals; Leukocyte activation; Pancreatic proteases; Rat; Splanchnic artery occlusion shock

Indexed keywords

CAMOSTAT MESILATE; DRUG DERIVATIVE; FORMYLMETHIONYL LEUCYL PHENYLALANINE METHYL ESTER; FORMYLMETHIONYL-LEUCYL-PHENYLALANINE METHYL ESTER; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GABEXATE; PHOSPHOLIPASE A; PROTEINASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; ARTICLE; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IN VITRO STUDY; INFLAMMATION; INTESTINE; LEUKOCYTE; MALE; METABOLISM; MULTIPLE ORGAN FAILURE; NEUTROPENIA; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REPERFUSION; SHOCK; SPLANCHNIC BLOOD FLOW; SPRAGUE DAWLEY RAT; SURVIVAL RATE;

ANIMALS; BLOOD PRESSURE; ENDOPEPTIDASES; GABEXATE; HUMANS; INFLAMMATION; INTESTINES; LEUKOCYTES; MALE; MULTIPLE ORGAN FAILURE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPENIA; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SHOCK; SPLANCHNIC CIRCULATION; SURVIVAL RATE;

EID: 0036518005     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200203000-00008     Document Type: Article

References (35)

1. Barroso-Aranda J, Schmid-Schönbein GW, Zweifach BW, Engler RL: Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res 63:437-447, 1988.
2. Schoenberg MH, Beger HG: Reperfusion injury after intestinal ischemia. Crit Care Med 21:1376-1386, 1993.
3. Schmid-Schönbein GW, Hugli TE, Kistler EB, Sofianos A, Mitsuoka H: Pancreatic enzymes and microvascular cell activation in multiorgan failure. Microcirculation 8:5-14, 2001.
4. Xiao F, Eppihimer MJ, Young JA, Nguyen K, Carden DL: Lung neutrophil retention and injury after intestinal ischemia/reperfusion. Microcirculation 4: 359-367, 1997.
5. Gerkin TM, Oldham KT, Guice KS, Hinshaw DB, Ryan US: Intestinal ischemia-reperfusion injury causes pulmonary endothelial cell ATP depletion. Ann Surg 217:48-56, 1993.
6. Kistler EB, Hugli T, Schmid-Schönbein GW: The pancreas as a source of cardiovascular cell activating factors. Microcirculation 7:183-192, 2000.
7. Kistler EB, Lefer AM, Hugli TE, Schmid-Schönbein GW: Plasma activation during splanchnic arterial occlusion shock. Shock 14:30-34, 2000.
8. Freise J, Magerstedt P, Schmid K: Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine. Enzyme 30:209-212, 1983.
9. Iwaki M, Ino Y, Motoyoshi A, Ozeki M, Sato T, Kurumi M, Aoyama T: Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats. Jpn J Pharmacol 41:155-162, 1986.
10. Mitsuoka H, Kistler EB, Schmid-Schönbein GW: Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes. Proc Natl Acad Sci USA 97:1772-1777, 2000.
11. Schmid-Schönbein GW, Skalak R, Chien S: Leukocyte protopodia. In: Schmid-Schönbein GW, Woo SL-Y, Zweifach BW (eds): Frontiers in Biomechanics. Springer, New York, 1986.
12. Chang RR, Chien NT, Chen CH, Jan KM, Schmid-Schönbein GW, Chien S: Spontaneous activation of circulating granulocytes in patients with acute myocardial and cerebral diseases. Biorheology 29:549-561, 1992.
13. Takase S, Schmid-Schönbein G, Bergan JJ: Leukocyte activation in patients with venous insufficiency. J Vasc Surg 30:148-156, 1999.
14. Pitzer JE, Del Zoppo GJ, Schmid-Schönbein GW: Neutrophil activation in smokers. Biorheology 33:45-58, 1996.
15. Suematsu M, Schmid-Schönbein GW, Chavez-Chavez RH, Yee TT, Tamatani T, Miyasaka M, Delano FA, Zweifach BW: In vivo visualization of oxidative changes in microvessels during neutrophil activation. Am J Physiol 264:H881-H891, 1993.
16. Bounous G, Menard D, de Medicis E: Role of pancreatic proteases in the pathogenesis of ischemic enteropathy. Gastroenterology 73:102-108, 1977.
17. Koike K, Moore EE, Moore FA, Read RA, Carl VS, Banerjee A: Gut ischemia/ reperfusion produces lung injury independent of endotoxin. Crit Care Med 22:1438-1444, 1994.
18. Mainous MR, Ertel W, Chaudry IH, Deitch EA: The gut: a cytokine-generating organ in systemic inflammation? Shock 4:193-199, 1995.
19. Chang TW: Improvement of survival from hemorrhagic shock by enterectomy in rats: finding to implicate the role of the gut for irreversibility of hemorrhagic shock. J Trauma 42:223-230, 1997.
20. Moore EE, Moore FA, Franciose RJ, Kim FJ, Biffl WL, Banerjee A: The post-ischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 37:881-887, 1994.
21. 2) and hydroxyl radical production by human polymorphonuclear leukocytes. Hepato-Gastroenterology 39:59-61, 1992.
22. Kinoshita M, Ono S, Aosasa S, Mochizuki H: Comparative study of different protease inhibitors on disseminated intravascular coagulation induced by thrombin-added endotoxin in rabbits. Gendai-Iryou 24:2831-2845, 1992.
23. Yedgar S, Dan P, Dagan A, Ginsburg I, Lossos IS, Breuer R: Control of inflammatory processes by cell-impermeable inhibitors of phospholipase A2. Agents Actions 46(Suppl):77-84, 1995.
24. Kistler EB: Humoral Mechanisms of Cellular Activation in Ischemic Shock. PhD thesis. University of California, La Jolla, CA, 1998.
25. Glenn TM, Lefer AM: Significance of splanchnic proteases in the production of a toxic factor in hemorrhagic shock. Circ Res 29:338-349, 1971.
26. Tompkins SD, Gregory S, Hoyt DB, Ozkan AN: In vitro inhibition of IL-2 biosynthesis in activated human peripheral blood mononucleur cells by a trauma-induced glycopeptide. Immunol Lett 23:205-209, 1990.
27. Ferguson WW, Glenn TM, Lefer AM: Mechanisms of production of circulatory shock factors in isolated perfused pancreas. Am J Physiol 222:450-457, 1972.
28. Granger DN, Rutili G, McCord JM: Role of superoxide radicals in intestinal ischemia. Gastroenterology 81:9-15, 1981.
29. 2-dependent type. J Biol Chem 265:14170-14175, 1990.
30. Parks DA, Williams TK, Beckman JS: Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 254:G768-G774, 1988.
31. Mitsuoka H, Schmid-Schönbein GW: Mechanisms for blockade of in vivo activator production in the ischemic intestine and multi-organ failure. Shock 14:522-527, 2000.
32. Lefer AM, Barenholz Y: Pancreatic hydrolases and the formation of a myocardial depressant factor in shock. Am J Physiol 223:1103-1109, 1972.
33. Upperman JS, Deitch EA, Guo W, Lu Q, Xu D: Post-hemorrhagic shock mesenteric lymph is cytotoxic to endothelial cells and activates neutrophils [see comments]. Shock 10:407-414, 1998.
34. Debek W, Chyczewski L, Oldhafer KJ: BN52021 inhibits activation of peritoneal mast cells caused by hemorrhage and blood volume restoration. Polish J Pathol 50:259-267, 1999.
35. Zhao K, Kirman I, Tschepen I, Schwab R, Weksler M: Peritoneal lavage reduces lipopolysaccharide-induced elevation of serum TNF-alpha and IL-6 mortality in mice. Inflammation 21:379-390, 1997.